Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma

Condition:   NK/T Cell Lymphoma Nos Interventions:   Drug: Sintilimab;   Drug: Lenalidomide Sponsor:   Beijing Tongren Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials